4//SEC Filing
Benaim Ely 4
Accession 0001645113-22-000017
CIK 0001645113other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 6:18 PM ET
Size
12.8 KB
Accession
0001645113-22-000017
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Benaim Ely
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2022-03-03+17,371→ 45,570 total - Sale
Ordinary Shares
2022-03-03$74.50/sh−803$59,822→ 44,767 total - Sale
Ordinary Shares
2022-03-04$70.41/sh−1,510$106,315→ 43,257 total - Award
Options to Buy Ordinary Shares
2022-03-03$80.59/sh+30,422$2,451,709→ 30,422 totalExercise: $80.59From: 2023-03-01Exp: 2032-02-29→ Ordinary Shares (30,422 underlying) - Award
Options to Buy Ordinary Shares
2022-03-03$80.59/sh+5,452$439,377→ 5,452 totalExercise: $80.59From: 2023-03-01Exp: 2032-02-29→ Ordinary Shares (5,452 underlying)
Footnotes (4)
- [F1]Represents restricted share units that are scheduled to vest in equal installments on March 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Options to buy 30,422 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
- [F4]Options to buy 5,452 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001632237
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 6:18 PM ET
- Size
- 12.8 KB